BMY Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.09%

Insider Buying (Last 12 Months): $672,994.06

Insider Selling (Last 12 Months): $0.00

Bristol-Myers Squibb Insider Trading History Chart

Bristol-Myers Squibb Share Price & Price History

^$50.91

▲ +0.79 (1.58%)

As of 09/27/2024 09:50 PM ET

Days: 30 | 90 | 365

What is Nvidia’s New $1 Trillion SuperProject?

From Weiss Ratings | Ad

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.

Bristol-Myers Squibb Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/5/2023	Christopher S. Boerner	CEO	Buy	2,000	$49.78	$99,560.00	82,672
11/28/2023	Christopher S. Boerner	CEO	Buy	3,071	$48.86	$150,049.06	79,384
11/20/2023	Theodore R. Samuels, II	Director	Buy	8,500	$49.81	$423,385.00	35,500
8/24/2023	Ann Powell	EVP	Sell	17,986	$61.25	$1,101,642.50	27,868
8/3/2023	Robert M. Plenge	EVP	Sell	732	$61.14	$44,754.48	6,584
5/3/2023	Rupert Vessey	EVP	Sell	50,385	$67.06	$3,378,818.10	47,751
2/6/2023	Ann Powell	EVP	Sell	11,183	$74.69	$835,258.27	23,043
2/6/2023	Giovanni Caforio	CEO	Sell	240,000	$74.65	$17,916,000.00	236,104
11/9/2022	Ann Powell	EVP	Sell	16,250	$80.45	$1,307,312.50	34,226
11/7/2022	Rupert Vessey	EVP	Sell	45,910	$78.88	$3,621,380.80	57,079
9/20/2022	Giovanni Caforio	CEO	Sell	25,000	$69.71	$1,742,750.00	476,104
9/15/2022	Giovanni Caforio	CEO	Sell	50,000	$71.84	$3,592,000.00	501,104
9/14/2022	Ann Powell	EVP	Sell	25,000	$70.75	$1,768,750.00	50,476
9/13/2022	David V. Elkins	CFO	Sell	133,951	$71.30	$9,550,706.30	100,460
6/13/2022	Giovanni Caforio	CEO	Sell	30,000	$74.04	$2,221,200.00	551,104
6/6/2022	Sandra Leung	EVP	Sell	65,000	$74.89	$4,867,850.00	308,627
3/21/2022	Giovanni Caforio	CEO	Sell	25,000	$71.52	$1,788,000.00
3/16/2022	Rupert Vessey	EVP	Sell	74,559	$69.25	$5,163,210.75
3/14/2022	Christopher S. Boerner	EVP	Sell	29,532	$69.20	$2,043,614.40
3/14/2022	Karen Murphy Santiago	SVP	Sell	6,577	$69.19	$455,062.63
2/24/2022	Giovanni Caforio	CEO	Sell	30,000	$67.00	$2,010,000.00
11/24/2021	Paul von Autenried	EVP	Sell	17,353	$56.92	$987,732.76
11/22/2021	Paul von Autenried	EVP	Sell	18,363	$57.17	$1,049,812.71

Wall Street Insider Issues Crash Prediction

From Stansberry Research | Ad

Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilson, an extremely rare window in the markets is about to open. It's an often-misunderstood market setup we've only seen 13 times since 1920. The last time this happened, it minted a million brand-new millionaires – in a single year. But Tilson says this unique window in the markets could close much sooner than anyone realizes, leaving most investors in the dust, while making a select few incredibly rich.

Get our No. 1 stock (with 500%-plus upside potential) for this rare market event now.

SEC Filings (Institutional Ownership Changes) for Bristol-Myers Squibb (NYSE:BMY)

76.41% of Bristol-Myers Squibb stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Bristol-Myers Squibb Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/23/2024	Centaurus Financial Inc.	8,999	$0.37M	0.0%	-17.0%	0.000%
9/20/2024	Anchor Investment Management LLC	15,650	$0.65M	0.1%	-3.7%	0.001%
9/10/2024	SS&H Financial Advisors Inc.	47,125	$1.96M	0.8%	-2.1%	0.002%
9/10/2024	Prio Wealth Limited Partnership	29,973	$1.25M	0.0%	-2.8%	0.001%
9/9/2024	Heritage Wealth Management Inc.	9,308	$0.37M	0.1%	N/A	0.000%
9/9/2024	Lazari Capital Management Inc.	23,163	$0.96M	0.4%	-6.2%	0.001%
9/5/2024	Sanctuary Advisors LLC	176,933	$7.94M	0.1%	N/A	0.009%
8/30/2024	Strategic Investment Solutions Inc. IL	1,323	$55K	0.0%	N/A	0.000%
8/28/2024	Birmingham Capital Management Co. Inc. AL	45,141	$1.88M	0.7%	+3.2%	0.002%
8/28/2024	Souders Financial Advisors	5,875	$0.24M	0.0%	-14.0%	0.000%
8/27/2024	Clearbridge Investments LLC	106,270	$4.41M	0.0%	-14.4%	0.005%
8/27/2024	Dana Investment Advisors Inc.	149,261	$6.20M	0.2%	-54.9%	0.007%
8/27/2024	KPP Advisory Services LLC	7,365	$0.31M	0.1%	-7.2%	0.000%
8/27/2024	New Century Financial Group LLC	21,234	$0.88M	0.4%	+1.4%	0.001%
8/26/2024	Teachers Retirement System of The State of Kentucky	163,420	$6.79M	0.1%	-53.0%	0.008%
8/26/2024	Founders Financial Alliance LLC	8,390	$0.35M	0.1%	+18.1%	0.000%
8/22/2024	Cetera Investment Advisers	548,206	$22.77M	0.1%	-4.6%	0.027%
8/22/2024	3Chopt Investment Partners LLC	45,339	$1.88M	0.6%	+19.7%	0.002%
8/21/2024	SPC Financial Inc.	5,849	$0.24M	0.0%	-18.4%	0.000%
8/21/2024	Advisory Alpha LLC	9,203	$0.38M	0.0%	-8.4%	0.000%
8/21/2024	Truist Financial Corp	1,551,457	$64.43M	0.1%	-6.4%	0.077%
8/19/2024	EP Wealth Advisors LLC	39,416	$1.64M	0.0%	-16.8%	0.002%
8/19/2024	Kimelman & Baird LLC	22,432	$0.93M	0.1%	N/A	0.001%
8/19/2024	B. Riley Wealth Advisors Inc.	163,095	$6.77M	0.2%	-12.2%	0.008%
8/16/2024	Regal Investment Advisors LLC	35,976	$1.49M	0.1%	+39.7%	0.002%
8/16/2024	Quarry LP	1,123	$47K	0.0%	N/A	0.000%
8/16/2024	Twin Lakes Capital Management LLC	5,738	$0.24M	0.1%	-18.8%	0.000%
8/16/2024	Wallace Advisory Group LLC	6,646	$0.28M	0.2%	+8.9%	0.000%
8/16/2024	William B. Walkup & Associates Inc.	3,636	$0.15M	0.1%	N/A	0.000%
8/16/2024	Sunbelt Securities Inc.	18,943	$0.79M	0.1%	+87.9%	0.001%
8/16/2024	Front Row Advisors LLC	948	$39K	0.0%	-25.5%	0.000%
8/16/2024	NewEdge Advisors LLC	274,740	$11.41M	0.1%	+118.5%	0.014%
8/16/2024	Northeast Financial Consultants Inc	41,805	$1.74M	0.1%	-7.9%	0.002%
8/16/2024	Silver Lake Advisory LLC	29,350	$1.22M	0.2%	+1.2%	0.001%
8/16/2024	Creative Planning	531,970	$22.09M	0.0%	+38.8%	0.026%
8/16/2024	Doheny Asset Management CA	8,963	$0.37M	0.2%	N/A	0.000%
8/16/2024	Algert Global LLC	7,901	$0.33M	0.0%	N/A	0.000%
8/16/2024	Aviso Wealth Management	11,141	$0.46M	0.3%	-34.7%	0.001%
8/16/2024	MidWestOne Financial Group Inc.	27,830	$1.16M	0.2%	+22.1%	0.001%
8/16/2024	Texas Capital Bank Wealth Management Services Inc	31,628	$1.31M	0.1%	-1.0%	0.002%
8/16/2024	Raab & Moskowitz Asset Management LLC	19,581	$0.81M	0.2%	-2.9%	0.001%
8/15/2024	Susquehanna Fundamental Investments LLC	972,243	$40.38M	0.9%	N/A	0.048%
8/15/2024	First County Bank CT	16,992	$0.71M	0.4%	-6.4%	0.001%
8/15/2024	Scientech Research LLC	30,081	$1.25M	0.3%	N/A	0.001%
8/15/2024	Legal & General Group Plc	20,225,040	$839.95M	0.2%	+3.8%	0.998%
8/15/2024	Lighthouse Investment Partners LLC	44,726	$1.86M	0.1%	-59.0%	0.002%
8/15/2024	Mackenzie Financial Corp	505,654	$21M	0.0%	-13.3%	0.025%
8/15/2024	The Manufacturers Life Insurance Company	1,681,594	$69.84M	0.1%	+2.5%	0.083%
8/15/2024	Marathon Capital Management	8,720	$0.36M	0.1%	-92.4%	0.000%
8/15/2024	MBB Public Markets I LLC	189,245	$7.86M	0.2%	+208.8%	0.009%
8/15/2024	Daymark Wealth Partners LLC	77,811	$3.23M	0.1%	-2.2%	0.004%
8/15/2024	Ameriprise Financial Inc.	17,663,295	$733.55M	0.2%	-10.6%	0.871%
8/15/2024	APG Asset Management N.V.	2,305,407	$89.33M	0.2%	-27.6%	0.114%
8/15/2024	APG Asset Management US Inc.	134,756	$5.57M	0.0%	-2.4%	0.007%
8/15/2024	AQR Capital Management LLC	2,676,296	$111.15M	0.2%	+14.0%	0.132%
8/15/2024	Ariel Investments LLC	619,211	$25.72M	0.3%	-2.4%	0.031%
8/15/2024	Armistice Capital LLC	490,868	$20.39M	0.3%	N/A	0.024%
8/15/2024	AXA S.A.	1,276,604	$53.02M	0.2%	-49.3%	0.063%
8/15/2024	AlTi Global Inc.	107,268	$4.46M	0.1%	+795.6%	0.005%
8/15/2024	Point72 Europe London LLP	79,103	$3.29M	0.3%	N/A	0.004%
8/15/2024	Point72 Hong Kong Ltd	258,297	$10.73M	0.6%	N/A	0.013%
8/15/2024	Toronto Dominion Bank	1,085,107	$45.06M	0.1%	-13.6%	0.054%
8/14/2024	Fred Alger Management LLC	41,496	$1.72M	0.0%	+9.9%	0.002%
8/14/2024	Insigneo Advisory Services LLC	20,914	$0.87M	0.1%	-13.2%	0.001%
8/14/2024	Sfmg LLC	28,853	$1.20M	0.1%	-2.1%	0.001%
8/14/2024	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	388,221	$16.12M	0.1%	+59.3%	0.019%
8/14/2024	Strata Wealth Advisors LLC	7,803	$0.32M	0.1%	N/A	0.000%
8/14/2024	Mill Creek Capital Advisors LLC	16,023	$0.67M	0.0%	+3.0%	0.001%
8/14/2024	Marshall Wace LLP	255,730	$10.62M	0.0%	-70.7%	0.013%
8/14/2024	Providence Capital Advisors LLC	51,983	$2.16M	0.5%	+1.6%	0.003%
8/14/2024	Resources Management Corp CT ADV	56,822	$2.36M	0.3%	-3.8%	0.003%
8/14/2024	Xponance Inc.	317,381	$13.18M	0.1%	+8.8%	0.016%
8/14/2024	Bank of Montreal Can	3,240,555	$146.80M	0.1%	-12.9%	0.160%
8/14/2024	Evergreen Capital Management LLC	35,081	$1.46M	0.1%	-85.1%	0.002%
8/14/2024	Magnetar Financial LLC	15,307	$0.64M	0.0%	N/A	0.001%
8/14/2024	Public Sector Pension Investment Board	77,950	$3.24M	0.0%	+71.2%	0.004%
8/14/2024	Steel Grove Capital Advisors LLC	33,180	$1.38M	0.2%	-11.9%	0.002%
8/14/2024	Commonwealth Financial Services LLC	7,738	$0.31M	0.1%	-7.1%	0.000%
8/14/2024	EverSource Wealth Advisors LLC	5,695	$0.24M	0.0%	+14.1%	0.000%
8/14/2024	Fairscale Capital LLC	2,422	$100K	0.1%	N/A	0.000%
8/14/2024	First City Capital Management Inc.	18,825	$0.78M	0.4%	-29.6%	0.001%
8/14/2024	Gabelli Funds LLC	366,450	$15.22M	0.1%	-7.5%	0.018%
8/14/2024	Itau Unibanco Holding S.A.	1,409	$59K	0.0%	N/A	0.000%
8/14/2024	Independent Franchise Partners LLP	14,600,621	$606.36M	5.6%	+4.0%	0.720%
8/14/2024	Fidelis Capital Partners LLC	13,068	$0.54M	0.1%	+85.1%	0.001%
8/14/2024	Epoch Investment Partners Inc.	1,074,685	$44.63M	0.2%	+17.4%	0.053%
8/14/2024	1832 Asset Management L.P.	1,000	$42K	0.0%	-98.7%	0.000%
8/14/2024	Heron Bay Capital Management	12,555	$0.52M	0.1%	N/A	0.001%
8/14/2024	Mount Yale Investment Advisors LLC	164,361	$6.83M	0.5%	-8.9%	0.008%
8/14/2024	Frank Rimerman Advisors LLC	41,819	$1.74M	0.1%	+37,238.4%	0.002%
8/14/2024	Holderness Investments Co.	38,932	$1.62M	0.4%	-12.3%	0.002%
8/14/2024	ProShare Advisors LLC	338,422	$14.06M	0.0%	+8.4%	0.017%
8/14/2024	Profund Advisors LLC	41,794	$1.74M	0.1%	-1.5%	0.002%
8/13/2024	Hancock Whitney Corp	24,291	$1.01M	0.0%	-1.1%	0.001%
8/13/2024	Symmetry Investments LP	13,400	$0.56M	0.1%	N/A	0.001%
8/13/2024	Kayne Anderson Rudnick Investment Management LLC	28,668	$1.19M	0.0%	-54.2%	0.001%
8/13/2024	Auxier Asset Management	24,546	$1.02M	0.2%	-2.5%	0.001%
8/13/2024	Legacy Financial Advisors Inc.	9,518	$0.40M	0.1%	+78.6%	0.000%
8/13/2024	Ensign Peak Advisors Inc	2,257,479	$93.75M	0.2%	-1.8%	0.111%
8/13/2024	Westwood Holdings Group Inc.	5,785	$0.24M	0.0%	-97.2%	0.000%

Data available starting January 2016

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Today's Range

Now: $50.91

$50.71

$52.16

50 Day Range

MA: $48.53

$42.71

$50.95

52 Week Range

Now: $50.91

$39.35

$58.46

Volume

23,035,199 shs

Average Volume

15,045,199 shs

Market Capitalization

$103.20 billion

P/E Ratio

N/A

Dividend Yield

4.79%

Beta

0.46

Who are the company insiders with the largest holdings of Bristol-Myers Squibb?: Bristol-Myers Squibb's top insider shareholders include:
Giovanni Caforio (CEO)
Christopher S Boerner (CEO)
Rupert Vessey (EVP)
Theodore R Samuels II (Director)
Ann Powell (EVP)
Robert M Plenge (EVP)
Learn More about top insider investors at Bristol-Myers Squibb.